Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)

Jin-Sun Park1 Department of Cardiology, Ajou University School of Medicine, Suwon

Joon-Han Shin1 Department of Cardiology, Ajou University School of Medicine, Suwon

Taek-Jong Hong2 Division of Cardiology, Pusan National University Hospital, Busan

Hong-Seog Seo3 Division of Cardiology, Korea University Guro Hospital, Korea University College of Medicine

Wan-Joo Shim4 Division of Cardiology, Korea University Anam Hospital

Sang-Hong Baek5 Cardiovascular Division, Catholic University of Korea, Seoul St Mary’s Hospital, Seoul

Jin-Ok Jeong6 Division of Cardiology, Chungnam National University Hospital, Daejeon

Youngkeun Ahn7 Division of Cardiology, Chonnam National University Hospital, Gwangju

Woong-Chol Kang8 Division of Cardiology, Gachon University Gil Hospital, Incheon

Young-Hak Kim9 Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan

Sang-Hyun Kim10 Division of Cardiology, Seoul Metropolitan Government Seoul National University Boramae Medical Center

Min-Su Hyon11 Division of Cardiology, Soonchunhyang University Hospital

Dong-Hoon Choi12 Division of Cardiology, Yonsei University Severance Hospital, Seoul

Chang-Wook Nam13 Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu

Tae-Ho Park14 Division of Cardiology, Dong-A University Hospital, Busan

Sang-Chol Lee15 Cardiovascular Imaging Center, Samsung Medical Center, Sungkyunkwan University School of Medicine

Hyo-Soo Kim16 Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, KoreaCorrespondence[email protected]

Your download is now in progress and you may close this window